Vycor Medical, Inc.

Total Valuation

Vycor Medical, Inc. carries a market capitalization of 2.24M, placing it among publicly traded companies globally. Its enterprise value stands at 3.00M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Vycor Medical, Inc. currently has 33.37M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 1.22, and the price-to-book ratio stands at -0.52.

Enterprise Valuation

On an enterprise value basis, Vycor Medical, Inc. trades at an EV/EBITDA multiple of 27.21 and an EV/FCF ratio of 17.98. The EV/Sales ratio of 1.66 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 62.25 provides insight into valuation relative to core operating earnings.

Financial Position

Vycor Medical, Inc. maintains a current ratio of 0.13, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -22.53, indicating conservative leverage, while an interest coverage ratio of 1.06 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Vycor Medical, Inc.'s stock has declined approximately -48.06202% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.10.

Income Statement

Over the trailing twelve months, Vycor Medical, Inc. generated 1.81M in revenue and converted that into -59,930.00 in net income, yielding earnings per share of 0.00. EBITDA reached 110,312.00, while operating income came in at 48,219.00.

Balance Sheet

Vycor Medical, Inc. holds 158,907.00 in cash and equivalents against 957,725.00 in total debt, resulting in a net debt position of 772,118.00. Total book value stands at -4.25M, with working capital of -4.29M providing operational flexibility.

Cash Flow

Vycor Medical, Inc. produced 61,384.00 in operating cash flow over the past twelve months. After subtracting -1,606.00 in capital expenditures, free cash flow totaled 59,778.00 - equivalent to 0.00 per share.

Margins

Vycor Medical, Inc. operates with a gross margin of 83.37, reflecting its pricing power and cost economics. The operating margin of 2.67 and net profit margin of -3.32 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 85.19 indicates the proportion of earnings distributed to shareholders.

Stock Splits

Vycor Medical, Inc.'s most recent stock split took place on January 15, 2013 with a 150:1 split ratio.

Scores

Vycor Medical, Inc. posts an Altman Z-Score of -61.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.